Fate Therapeutics, Inc.
NASDAQ:FATE
1.255 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -160.928 | -281.721 | -212.151 | -173.387 | -98.149 | -66.598 | -42.952 | -33.462 | -29.992 | -25.883 | -20.894 | -14.239 | -13.427 |
| Depreciation & Amortization
| 18.282 | 13.758 | 5.85 | 3.087 | 2.193 | 1.204 | 0.971 | 0.881 | 0.687 | 0.496 | 0.571 | 0.59 | 0.672 |
| Deferred Income Tax
| 0 | 0 | 5.067 | 1.676 | -0.478 | -0.335 | 0.005 | 0.171 | 0 | 0.003 | 0.026 | 0 | 0.121 |
| Stock Based Compensation
| 43.459 | 78.733 | 54.364 | 30.753 | 17.41 | 6.293 | 3.606 | 3.184 | 2.4 | 2.434 | 1.554 | 0.155 | 0.172 |
| Change In Working Capital
| 19.182 | -34.71 | 2.098 | -12.773 | 3.64 | 1.744 | 2.083 | 1.18 | 0.37 | 0.017 | 0.307 | 0 | 0.343 |
| Accounts Receivables
| 36.654 | -29.804 | -3.16 | -5.515 | 0.5 | -0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -5.907 | 1.554 | -4.277 | -4.254 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -28.94 | 14.252 | 5.907 | -1.554 | 4.277 | 4.254 | 2.511 | 1.561 | 0.477 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 11.468 | -19.158 | 5.258 | -7.258 | 3.14 | 2.244 | -0.428 | 1.18 | 0.37 | -0.146 | -1.271 | 0 | 0 |
| Other Non Cash Items
| -52.258 | -24.268 | -18.098 | 111.415 | -7.791 | 19.042 | -0.613 | -1.606 | 8.138 | 0.517 | 3.089 | 0.22 | 0.095 |
| Operating Cash Flow
| -132.263 | -248.208 | -162.87 | -39.229 | -83.175 | -38.65 | -36.905 | -29.823 | -18.397 | -22.419 | -15.373 | -13.274 | -12.145 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -6.153 | -35.566 | -50.704 | -4.932 | -7.395 | -2.303 | -1.725 | -0.457 | -1.498 | -0.882 | -0.244 | -0.709 | -0.002 |
| Acquisitions Net
| 0 | -202.317 | 273.319 | 156.144 | 150.058 | 0 | 0 | 0.018 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -358.81 | -404.796 | -968.159 | -277.344 | -248.858 | -55.66 | -39.971 | -19.675 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 477.628 | 607.113 | 694.84 | 121.2 | 98.8 | 57.5 | 31.5 | 16 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 202.317 | -273.319 | -156.144 | -150.058 | 1.84 | -8.471 | 0.018 | 0 | 0 | 0.006 | 0 | 0.202 |
| Investing Cash Flow
| 112.665 | 166.751 | -324.023 | -161.076 | -157.453 | -0.463 | -10.196 | -4.114 | -1.498 | -0.882 | -0.238 | -0.709 | 0.2 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -15 | 0 | 4.148 | -7.689 | -1.546 | 18.25 | 20.057 | -0.25 | 3.6 |
| Common Stock Issued
| 0.085 | 9.207 | 411.735 | 272.693 | 162.406 | 134.577 | 43.206 | 28.849 | 36.729 | 0.142 | 40.48 | 0.207 | 0.014 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.007 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.085 | 9.207 | 41.394 | 10.145 | 2.522 | 6.203 | 0.155 | 36.577 | 0.42 | 0.116 | 40.503 | 16.726 | 3.5 |
| Financing Cash Flow
| 0.085 | 9.207 | 453.129 | 282.838 | 149.928 | 140.78 | 47.444 | 57.737 | 35.603 | 18.366 | 60.56 | 16.683 | 7.107 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -19.513 | -72.25 | -33.764 | 82.533 | -90.7 | 101.667 | 0.343 | 23.8 | 15.708 | -4.935 | 44.949 | 2.7 | -4.838 |
| Cash At End Of Period
| 57.047 | 76.56 | 148.81 | 182.574 | 100.041 | 190.741 | 89.074 | 88.609 | 64.809 | 49.101 | 54.036 | 9.087 | 6.387 |